Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Merck signs supply deal with UNICEF for 3 mln courses of COVID-19 drug

by Reuters
Tuesday, 18 January 2022 11:50 GMT

Jan 18 (Reuters) - Merck & Co Inc and partner Ridgeback Biotherapeutics said on Tuesday they had signed a supply agreement with the United Nations Children's Fund (UNICEF) for 3 million courses of their COVID-19 drug. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

Our Standards: The Thomson Reuters Trust Principles.